Recent Finacing
Recent Raise
Gemini Therapeutics develops monoclonal antibodies, recombinant proteins and gene therapies targeting complement regulatory proteins for genetically defined dry AMD and related rare diseases, leveraging academic and industry collaborations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors